Navigation Links
The Global Cardiovascular Drugs Market to Decline at a CAGR of 10.47 Percent Over the Period 2012-2016
Date:8/8/2013

DUBLIN, August 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/f5rg4j/global) has announced the addition of the "Global Cardiovascular Drugs Market 2012-2016" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

One of the key factors affecting market growth is the over-dependency of the market on the US. The Global Cardiovascular Drugs market has also been witnessing an increase in R&D activities. However, the increase in healthcare expenditure could be one of the factors that will contribute to the growth of this market.

The key vendors dominating this market space are AstraZeneca plc, Bristol-Myers Squibb Co., Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.

The other vendors mentioned in the report are Abbott Laboratories, Forest Laboratories Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline plc, Solvay SA, Takeda Pharmaceutical Co. Ltd., and The Medicines Co.

Commenting on the report, an analyst from TechNavio's Healthcare team said: "In the last few years, the Healthcare industry has witnessed phenomenal growth in the APAC region. Emerging economies such as the APAC region, Eastern Europe, and Latin America hold vast growth potential. These regions are under-equipped to address the increase in the incidence of CVDs in the region. However, the increase in the incidence of CVDs and instances of patients frequently enduring long waits for therapeutic treatments are forcing healthcare organizations in the region to opt for cardiovascular drugs. Moreover, there has been substantial investment to initiate a significant number of projects in R&D across the developing countries. Hence, healthcare organizations in developing regions such as the APAC region and the Middle East are opting for cardiovascular drugs in accordance with the demand in specific countries. The increasing demand for cardiovascular drugs in the developing countries is boosting the growth of the global cardiovascular drugs market."

Companies Mentioned

- AstraZeneca plc
- Bristol-Myers Squibb Co.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi.
- Abbott Laboratories
- Forest Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- GlaxoSmithKline plc
- Solvay SA
- Takeda Pharmaceutical Co. Ltd.
- The Medicines Co.

For more information visit http://www.researchandmarkets.com/research/f5rg4j/global

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ... offering. ... market was valued at US$ 7,167.6 Mn in 2015, and ... at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... ... the ATA 2017 President’s Awards recipients, comprised of organizations and individuals who ... , The ATA 2017 President’s Awards recognize individuals and organizations on ...
(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... ... 26, 2017 , ... The National Business Research Institute (NBRI) ... of Emergency Medical Technicians and welcomes this organization to the NBRI Circle ... West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a ...
(Date:4/26/2017)... ... 2017 , ... Miami native and local periodontist Dr. John Paul Gallardo ... imagined back in 1991 that this journey would have taken me into so many ... years, Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more ... CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a more ... with fewer resources. It highlights the business’ principles, research and collaboration efforts in ...
Breaking Medicine News(10 mins):